GRISACTIN 250 (Grisactin 250 microcrystalline 250 mg)
Generic Name: griseofulvin
Pill with imprint GRISACTIN 250 is Yellow, Capsule-shape and has been identified as Grisactin 250 microcrystalline 250 mg. It is supplied by Wyeth-Ayerst Laboratories.
Grisactin 250 is used in the treatment of dermatophytosis; onychomycosis, toenail; tinea barbae; onychomycosis, fingernail; tinea capitis and belongs to the drug class miscellaneous antifungals. Risk cannot be ruled out during pregnancy. Grisactin 250 microcrystalline 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GRISACTIN 250
Grisactin 250
- Generic Name:
- griseofulvin
- Imprint:
- GRISACTIN 250
- Strength:
- microcrystalline 250 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antifungals
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Wyeth-Ayerst Laboratories
- National Drug Code (NDC):
- 00046-0443
More about Grisactin 250 (griseofulvin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Drug class: miscellaneous antifungals
- FDA Alerts (1)
Consumer resources
Other brands: Fulvicin P/G, Fulvicin U/F, Grifulvin V, Gris-PEG
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
